Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response—a prospective open-label study

被引：0
|
作者：
Naoki Hashimoto
Atsuhito Toyomaki
Minoru Honda
Satoru Miyano
Nobuyuki Nitta
Hiroyuki Sawayama
Yasufumi Sugawara
Keiichi Uemura
Noriko Tsukamoto
Tsukasa Koyama
Ichiro Kusumi
机构：
[1] Hokkaido University Graduate School of Medicine,Department of Psychiatry
[2] Child and Adolescent Psychiatry,Department of Psychiatry
[3] Department of Psychiatry University of California,undefined
[4] Honda Memorial Hospital,undefined
[5] Teine Hospital,undefined
[6] Sapporo Hanazono Hospital,undefined
[7] San-ai Hospital,undefined
[8] Psychiatric Medical Center,undefined
[9] Sapporo City General Hospital,undefined
[10] Hakodate Watanabe Hospital,undefined
[11] Oyachi Hospital,undefined
来源：
Annals of General Psychiatry | / 14卷
关键词：
Schizophrenia; Quetiapine; Switching; Antipsychotic; Negative symptom; Cognitive impairment; Treatment resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study
    Ishigooka, Jun
    Inada, Ken
    Niidome, Kazunari
    Aoki, Kazuo
    Kojima, Yoshitsugu
    Iwashita, Shuichi
    Yamada, Sakiko
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (04)
  • [22] Blonanserin augmentation in patients with schizophrenia - who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study
    Woo, Young Sup
    Park, Joo Eon
    Kim, Do-Hoon
    Sohn, Inki
    Hwang, Tae-Yeon
    Park, Young-Min
    Jon, Duk-In
    Jeong, Jong-Hyun
    Woo, Won-Myong Bahk Y. S.
    Jeong, J. H.
    Bahk, W. M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 202 - 203
  • [23] Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study
    Altamura, AC
    Salvadori, D
    Madaro, D
    Santini, A
    Mundo, E
    JOURNAL OF AFFECTIVE DISORDERS, 2003, 76 (1-3) : 267 - 271
  • [24] Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study
    Miller, Brian J.
    Claxton, Amy
    Du, Yangchun
    Weiden, Peter J.
    Potkin, Steven G.
    SCHIZOPHRENIA RESEARCH, 2019, 208 : 44 - 48
  • [25] Long-term safety and effectiveness of brexpiprazole in Japanese patients with schizophrenia: A 52-week, open-label study
    Ishigooka, Jun
    Iwashita, Shuichi
    Tadori, Yoshihiro
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2018, 72 (06) : 445 - 453
  • [26] A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis
    Davidson, M
    Harvey, PD
    Vervarcke, J
    Gagiano, CA
    De Hooge, JD
    Bray, G
    Dose, M
    Barak, Y
    Haushofer, M
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 15 (06) : 506 - 514
  • [27] Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial
    Gaebel, Wolfgang
    Schreiner, Andreas
    Bergmans, Paul
    de Arce, Rosario
    Rouillon, Frederic
    Cordes, Joachim
    Eriksson, Lars
    Smeraldi, Enrico
    NEUROPSYCHOPHARMACOLOGY, 2010, 35 (12) : 2367 - 2377
  • [28] Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
    Durgam, Suresh
    Greenberg, William M.
    Li, Dayong
    Lu, Kaifeng
    Laszlovszky, Istvan
    Nemeth, Gyorgy
    Migliore, Raffaele
    Volk, Stephen
    PSYCHOPHARMACOLOGY, 2017, 234 (02) : 199 - 209
  • [29] Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial
    Wolfgang Gaebel
    Andreas Schreiner
    Paul Bergmans
    Rosario de Arce
    Frédéric Rouillon
    Joachim Cordes
    Lars Eriksson
    Enrico Smeraldi
    Neuropsychopharmacology, 2010, 35 : 2367 - 2377
  • [30] The acute and long-term effectiveness of amisulpride in patients with schizophrenia: results of a 12-month open-label prospective follow-up study
    Ahn, Yong Min
    Lee, Kyu Young
    Kim, Chul-Eung
    Kang, Dae-Yeob
    Seok, Jeong-Ho
    Shin, Young Min
    Chung, In-Won
    Jun, Tae-Youn
    Chang, Jae Seung
    Kim, Yong Sik
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (08) : 568 - 577
12345